RxDoctor Payments Data

Sean Sester, DO

Family Medicine · Newport, KYNPI 1407376247

Payments from drug & device makers

$201in general payments, 2019–2025

Across 10 payments — averaging $20.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Currax Pharmaceuticals LLC$50
  • AbbVie$42
  • Corcept Therapeutics$24
  • Novo Nordisk$19
  • Pfizer$19
  • Verrica Pharmaceuticals Inc.$17
  • plus $31 from 2 others

What the payments were for

  • Food & beverage$15175%
  • Education$5025%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$201 in reported general payments places this provider in the 30th percentile of 1,559 family medicine providers in Kentucky.

See all family medicine providers in Kentucky

Medicare billing

Part B allowed, 2024
$23,295
Medicare patients
130
Services billed
1,238

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide41$67,494
JardianceEmpagliflozin54$56,910
MounjaroTirzepatide34$36,400
EliquisApixaban32$34,093
Trelegy ElliptaFluticasone/Umeclidin/Vilanter38$28,437
FarxigaDapagliflozin Propanediol14$14,695
SymbicortBudesonide/Formoterol Fumarate13$6,161
Albuterol Sulfate HfaAlbuterol Sulfate152$5,343
Lantus SolostarInsulin Glargine,hum.Rec.Anlog29$3,423
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate12$2,999
Gabapentin218$2,933
PaxlovidNirmatrelvir/Ritonavir11$2,866
Atorvastatin Calcium244$1,795
Celecoxib23$1,444
Metoprolol Succinate47$1,105

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$19$67,49441 claims
PfizerEliquis, Paxlovid$19$36,95943 claims
GSKTrelegy Ellipta$16$28,43738 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 30th percentile of 1,559 family medicine providers in Kentucky.

Other family medicine in Newport

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →